Company
Laguna Bio
Turning Microbes into Cancer Therapeutics
Also known as Laguna Biotherapeutics Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Laguna Biotherapeutics Inc.
Record updated 28 September 2026
About
Laguna is a biotechnology company developing next-generation microbial platforms designed to activate innate immune responses against cancer. By combining insights from microbiology and immunology, the company is building a new class of immunotherapies designed to be safer, scalable, and effective across multiple cancer types.
Funding snapshot
- Total raised
- $1.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $1.5M2022-09-13
Funding rounds
- Round, 2022
- $1.5M2022-09-13, SEC form D sold, 2 investors